Loading
Yanuki
SUBCATEGORY FEED
HIMS Stock: New Testosterone Push Builds as GLP-1 Market Crowds | Vanderbilt Celebrates 10 Years of Seacrest Studios: Impact on Patients and Families | ACA Subsidy Cliff: Millions Face Healthcare Premium Hikes in 2026 | Temple Hospital Nurses Authorize Strike Amid Contract Disputes | Impact of Federal Policy Changes on Rural Hospitals | Indiana Law Targets High Hospital Prices, Threatens Non-Profit Status | HIMS Stock: New Testosterone Push Builds as GLP-1 Market Crowds | Vanderbilt Celebrates 10 Years of Seacrest Studios: Impact on Patients and Families | ACA Subsidy Cliff: Millions Face Healthcare Premium Hikes in 2026 | Temple Hospital Nurses Authorize Strike Amid Contract Disputes | Impact of Federal Policy Changes on Rural Hospitals | Indiana Law Targets High Hospital Prices, Threatens Non-Profit Status

News / Healthcare

HIMS Stock: New Testosterone Push Builds as GLP-1 Market Crowds

Hims & Hers Health, Inc. (HIMS) is expanding its focus on testosterone therapies as competition intensifies in the GLP-1 weight-loss market. The company's stock experienced a boost following the announcement of its new Testosterone Rx+ offe...

HIMS Stock: New Testosterone Push Builds as GLP-1 Market Crowds Image via TipRanks
HIMS Stock Options Traders Are Pricing In a Huge Price Swing after Earnings
Weather Crime Politics Local Lottery Legal Local News Education Accidents Immigration